Fresh Tracks Therapeutics, Inc.

FRTXDelisted Dec 27, 2023

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000819050

SEC filings (opens in a new tab)

Fresh Tracks Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Jun 11, 2024; 15 institutions reported holding it in 13F filings for Q3 2023, worth $455.8K in total; no superinvestor held it.

Key figures

Market cap: –; Not available
Insider buys: 0; Open market, last 90 days
Insider sells: 0; Open market, last 90 days
13F holders: 15; Q3 2023, 0 vs. previous quarter
13F value: $455.8K; Reported value at the end of Q3 2023
Superinvestors holding: 0; At the end of Q3 2023

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2023: $8.01M; +15.3% year over year
Net income, FY2023: -$5.69M; No comparable prior period
Free cash flow, FY2023: -$4.34M; No comparable prior period
Revenue, Q4 FY2023: $0; −100.0% year over year

Revenue flow, FY2023

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2023: $5.69M (71.1% of revenue).

Superinvestors holding FRTX, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding FRTX at the end of Q3 2023.

Latest insider trades

See all insider trades

Open-market purchases and sales by Fresh Tracks Therapeutics, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jun 11, 2024 (view filing)	Jun 7-10	4 days	Exploration Capital, LLC10% Owner	PPurchase	+405.5K	$0.94	+$381.2K	+30.4%1.74M after	2 lots
May 31, 2024 (view filing)	May 29-31	2 days	Exploration Capital, LLC10% Owner	PPurchase	+10.4K	$0.9181	+$9.58K	+0.8%1.33M after	3 lots
May 23, 2024 (view filing)	May 21-23	2 days	Exploration Capital, LLC10% Owner	PPurchase	+22.9K	$0.9097	+$20.8K	+1.8%1.32M after	3 lots
May 20, 2024 (view filing)	May 16-20	4 days	Exploration Capital, LLC10% Owner	PPurchase	+74.6K	$0.9199	+$68.6K	+6.1%1.30M after	2 lots
May 8, 2024 (view filing)	May 6	2 days	Exploration Capital, LLC10% Owner	PPurchase	+320	$0.89	+$284.8	0.0%1.23M after
May 3, 2024 (view filing)	May 1-3	2 days	Exploration Capital, LLC10% Owner	PPurchase	+164.9K	$0.9198	+$151.7K	+15.5%1.23M after	3 lots
Apr 23, 2024 (view filing)	Apr 19-23	4 days	Exploration Capital, LLC10% Owner	PPurchase	+21.5K	$0.9021	+$19.4K	+2.1%1.06M after	3 lots
Apr 11, 2024 (view filing)	Apr 9-10	2 days	Exploration Capital, LLC10% Owner	PPurchase	+3.19K	$0.88	+$2.81K	+0.3%1.04M after	2 lots
Apr 5, 2024 (view filing)	Apr 3-5	2 days	Exploration Capital, LLC10% Owner	PPurchase	+17.4K	$0.91	+$15.8K	+1.7%1.04M after	3 lots
Apr 1, 2024 (view filing)	Mar 27-Apr 1	5 daysLate	Exploration Capital, LLC10% Owner	PPurchase	+54.6K	$0.8999	+$49.1K	+5.7%1.02M after	3 lots

Top 10 13F holders, Q3 2023

See all 15 holders

The largest institutional positions in Fresh Tracks Therapeutics, Inc. at the end of Q3 2023; share changes are against Q2 2023.

Institutions holding FRTX in Q3 2023
Institution	Shares	Value	% of portfolio	Change in shares	Action
JBF Capital, Inc.	295,000	$286.1K	0.06%	+295,000	New
GTS Securities LLC	50,100	$48.6K	0.00%	+50,100	New
Virtu Financial LLC	43,558	$42.0K	0.00%	+30,716+239.2%	Added
Geode Capital Management, LLC	41,449	$40.2K	0.00%	+26,801+183.0%	Added
Vanguard Group Inc	23,060	$22.4K	0.00%	00.0%	Unchanged
Tower Research Capital LLC (TRC)	10,224	$9.92K	0.00%	−254−2.4%	Reduced
BlackRock Inc.	4,790	$4.65K	0.00%	00.0%	Unchanged
Ronald Blue Trust, Inc.	916	$1.00K	0.00%	00.0%	Unchanged
Steward Partners Investment Advisory, LLC	709	$688	0.00%	00.0%	Unchanged
Wells Fargo & Company	154	$150	0.00%	+11+7.7%	Added